Clinical Trial Update: Population Pharmacokinetic Study of Colistin in Patients Infected With Multiresistant Gram-negative Bacteria [Phase 1]

View source ↗

Summary

This Phase 1 population pharmacokinetic study evaluates Colistin in patients infected with multidrug-resistant Gram-negative bacteria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gram-negative Bacterial Infection

Drugs mentioned

• Colistin (colistin)

Snippet

Sponsor: Poitiers University Hospital | Conditions: Gram-negative Bacteria | Phase 1 | Status: COMPLETED